Mesenchymal Stem Cells and Cardiomyocytes Interplay to Prevent Myocardial Hypertrophy

Bone marrow-derived mesenchymal stem cells (BMSCs) have emerged as a promising therapeutic strategy for cardiovascular disease. However, there is no evidence so far that BMSCs can heal pathological myocardial hypertrophy. In this study, BMSCs were indirectly cocultured with neonatal rat ventricular...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Stem Cells Transl Med
Autori principali: Cai, Benzhi, Tan, Xueying, Zhang, Yong, Li, Xingda, Wang, Xinyue, Zhu, Jiuxin, Wang, Yang, Yang, Fan, Wang, Baoqiu, Liu, Yanju, Xu, Chaoqian, Pan, Zhenwei, Wang, Ning, Yang, Baofeng, Lu, Yanjie
Natura: Artigo
Lingua:Inglês
Pubblicazione: AlphaMed Press 2015
Soggetti:
Tissue-Specific Progenitor and Stem Cells
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4675503/
https://ncbi.nlm.nih.gov/pubmed/26586774
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5966/sctm.2015-0032
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi